Abstract
Early in development, the nervous system overproduces neurons and synapses. Throughout development, this initial surplus of cells is reduced and the connections between them refined via tightly controlled cell death. Cell death is regulated by a family of secreted proteins known as the neurotrophins. The four members of this family, nerve growth factor (NGF), brain-derived neurotrophic factor (BDNF), neurotrophin 3 (NT-3), and neurotrophin 4 (NT-4), have unique expression patterns and act through their receptors on distinct neuronal populations at different stages throughout development and in adulthood. In addition to controlling the balance between neuronal survival and cell death, neurotrophins regulate neuronal differentiation, connectivity and function, making them essential for proper nervous system development. Dysregulation of neurotrophins or their receptors at critical stages during development results in neurodevelopmental disorders that arise from perturbations in neuronal survival, proliferation, differentiation, synaptic function, connectivity, and plasticity.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Abbreviations
- Akt:
-
Protein kinase B
- APAF-1:
-
Apoptotic protease activating factor 1
- ASD:
-
Autism spectrum disorder
- BDNF:
-
Brain-derived neurotrophic factor
- BMP:
-
Bone morphogenic protein
- Cl−:
-
Chloride
- CNS:
-
Central nervous system
- CREB:
-
cAMP response element-binding protein
- Cyt c:
-
Cytochrome c/ cytochrome complex
- DLPFC:
-
Dorsolateral prefrontal cortex
- DNA:
-
Deoxyribonucleic acid
- DRG:
-
Dorsal root ganglia
- E:
-
Embryonic day
- Elk-1:
-
E26 transformation-specific-like protein 1
- E-LTP:
-
Early-phase long-term potentiation
- ENS:
-
Enteric nervous system
- EPS-8:
-
Epidermal growth factor receptor kinase substrate 8
- ERK:
-
Extracellular signal-regulated kinase
- FADD:
-
Fas-associated protein with death domain
- FRS2:
-
Fibroblast growth factor substrate 2
- GABA:
-
ɣ-aminobutyric acid
- GDI:
-
Guanine-nucleotide dissociation inhibitor
- GDNF:
-
Glial cell line-derived neurotrophic factor
- GRB2:
-
Growth factor receptor-bound protein 2
- IPSC:
-
Inhibitory postsynaptic potential
- JNK:
-
c-Jun N-terminal kinase
- KCC2:
-
Potassium chloride cotransporter 2
- LGN:
-
Lateral geniculate nucleus
- LTD:
-
Long-term depression
- LTP:
-
Long-term potentiation
- L-LTP:
-
Late-phase long-term potentiation
- MAG:
-
Myelin-associated glycoprotein
- MAP:
-
Mitogen-activated protein kinase
- MBP:
-
Myelin basic protein
- mEPSC:
-
Mini excitatory postsynaptic current
- mRNA:
-
Messenger ribonucleic acid
- MS:
-
Multiple sclerosis
- mTOR:
-
Mammalian target of rapamycin
- NKCC1:
-
Na-K-Cl cotransporter
- NMDA:
-
N-methyl-D-aspartate receptor
- NGF:
-
Nerve growth factor
- NF-κB:
-
Nuclear factor-κB
- Nogo-R:
-
Nogo-66 receptor
- NR2B:
-
N-methyl D-aspartate receptor subtype 2B
- NRAGE:
-
Neurotrophin receptor-interacting melanoma antigen gene homolog
- NRIF:
-
Neurotrophin receptor interacting factor
- NT-3:
-
Neurotrophin 3
- NT-4:
-
Neurotrophin 4
- OMgp:
-
Oligodendrocyte-myelin glycoprotein
- P:
-
Postnatal day
- p75NTR:
-
Pan-neurotrophin receptor
- PCD:
-
Programmed cell death
- PI3K:
-
Phosphoinositide-3′-kinase
- PKC:
-
Protein kinase C
- PLC-γ1:
-
Phospholipase C gamma-1
- PNS:
-
Peripheral nervous system
- PSD95:
-
Postsynaptic density protein 95
- SC-1:
-
Schwann cell factor 1
- SHC:
-
Src homology 2 domain containing
- SNP:
-
Single-nucleotide polymorphisms
- SorCS2:
-
Sortilin-related VPS10 domain containing receptor 2
- SOS:
-
Son of sevenless
- RhoA:
-
Ras homolog family member A
- ROCK:
-
Rho-associated protein kinase
- TGF-β:
-
Transforming growth factor-β
- TLE:
-
Temporal lobe epilepsy
- TRAF:
-
Tumor necrosis factor receptor-associated factor
- Trk:
-
Tropomyosin-related kinase
References
Maghsoudi N, Zakeri Z, Lockshin RA. Programmed cell death and apoptosis - where it came from and where it is going: from Elie Metchnikoff to the control of caspases. Exp Oncol. 2012;34(3):146–52.
Kuan CY, Roth KA, Flavell RA, Rakic P. Mechanisms of programmed cell death in the developing brain. Trends Neurosci. 2000;23(7):291–7.
Yamaguchi Y, Miura M. Programmed cell death in neurodevelopment. Dev Cell. 2015;32(4):478–90.
Shi Y. Caspase activation, inhibition, and reactivation: a mechanistic view. Protein Sci. 2004;13(8):1979–87.
Nijhawan D, Honarpour N, Wang X. Apoptosis in neural development and disease. Annu Rev Neurosci. 2000;23:73–87.
Cecconi F, Alvarez-Bolado G, Meyer BI, Roth KA, Gruss P. Apaf1 (CED-4 homolog) regulates programmed cell death in mammalian development. Cell. 1998;94(6):727–37.
Kuan CY, Yang DD, Samanta Roy DR, Davis RJ, Rakic P, Flavell RA. The Jnk1 and Jnk2 protein kinases are required for regional specific apoptosis during early brain development. Neuron. 1999;22(4):667–76.
Sabapathy K, Jochum W, Hochedlinger K, Chang L, Karin M, Wagner EF. Defective neural tube morphogenesis and altered apoptosis in the absence of both JNK1 and JNK2. Mech Dev. 1999;89(1–2):115–24.
Hamburger V, Levi-Montalcini R. Proliferation, differentiation and degeneration in the spinal ganglia of the chick embryo under normal and experimental conditions. J Exp Zool. 1949;111(3):457–501.
Levi-Montalcini R. The nerve growth factor 35 years later. Science. 1987;237(4819):1154–62.
Huang EJ, Reichardt L. Neurotrophins: Roles in neuronal development and function. Annu Rev Neurosci. 2001;24:677–736.
Levi-Montalcini R, Angeletti PU. Nerve growth factor. Physiol Rev. 1968;48(3):534–69.
Davies AM. The neurotrophic hypothesis: where does it stand? Philos Trans R Soc B Biol Sci. 1996;351(1338):389–94.
Davies AM. Regulation of neuronal survival and death by extracellular signals during development. EMBO J. 2003;22(11):2537–45.
Cowan WM. Viktor Hamburger and Rita Levi-Montalcini: the path to the discovery of nerve growth factor. Annu Rev Neurosci. 2001;24(1):551–600.
Barde YA, Edgar D, Thoenen H. Purification of a new neurotrophic factor from mammalian brain. EMBO J. 1982;1(5):549–53.
Hohn A, Leibrock J, Bailey K, Barde Y-A. Identification and characterization of a novel member of the nerve growth factor /brain-derived neurotrophic factor family. Nature. 1990;344(March):339–41.
Maisonpierre P, Belluscio L, Squinto S, Ip N, Furth M, Lindsay R, et al. Neurotrophin-3: a neurotrophic factor related to NGF and BDNF. Science. 1990;247(4949):1446–51.
Ip NY, Ibanez CF, Nye SH, McClain J, Jones PF, Gies DR, et al. Mammalian neurotrophin-4: structure, chromosomal localization, tissue distribution, and receptor specificity. Proc Natl Acad Sci U S A. 1992;89(7):3060–4.
Hallböök F, Ibáñez CF, Persson H. Evolutionary studies of the nerve growth factor family reveal a novel member abundantly expressed in xenopus ovary. Neuron. 1991;6(5):845–58.
Berkemeier LR, Winslow JW, Kaplan DR, Nikolics K, Goeddel DV, Rosenthal A. Neurotrophin-5: a novel neurotrophic factor that activates trk and trkB. Neuron. 1991;7(5):857–66.
Deinhardt K, Chao MV. Trk Receptors. Trk Receptors Handb Exp Pharmacol. 2014;220:103–19.
Eide FF, Vining ER, Eide BL, Zang K, Wang XY, Reichardt LF. Naturally occurring truncated trkB receptors have dominant inhibitory effects on brain-derived neurotrophic factor signaling. J Neurosci. 1996;16(10):3123–9.
Fulgenzi G, Tomassoni-Ardori F, Babini L, Becker J, Barrick C, Puverel S, et al. BDNF modulates heart contraction force and long-term homeostasis through truncated TrkB.T1 receptor activation. J Cell Biol. 2015;210(6):1003–12.
Gentry JJ, Barker PA, Carter BD. The p75 neurotrophin receptor: multiple interactors and numerous functions. Prog Brain Res. 2004;146:25–39.
Chao MV. Neurotrophins and their receptors: a convergence point for many signalling pathways. Nat Rev Neurosci. 2003;4(4):299–309.
Mahadeo D, Kaplan L, Chao MV, Hempstead BL. High affinity nerve growth factor binding displays a faster rate of association than p140trk binding. J Biol Chem. 1994;269(9):6884–91.
Schwab ME. Nogo and axon regeneration. Curr Opin Neurobiol. 2004;14(1):118–24.
Nykjaer A, Lee R, Teng KK, Jansen P, Madsen P, Nielsen MS, et al. Sortilin is essential for proNGF- induced neuronal cell death. Nature. 2004;427(6977):843–8.
Lu B, Pang PT, Woo NH. The yin and yang of neurotrophin action. Nat Rev Neurosci. 2005;6(8):603–14.
Kraemer BR, Yoon SO, Carter BD. The biological functions and signaling mechanisms of the p75 Neurotrophin receptor. Handb Exp Pharmacol. 2014;220:121–64.
Kaplan DR, Miller FD. Neurotrophin signal transduction in the nervous system. Curr Opin Neurobiol. 2000;10(3):381–91.
Fahnestock M, Shekari A. ProNGF and neurodegeneration in Alzheimer’s disease. Front Neurosci. 2019;13:129.
Teng HK, Teng KK, Lee R, Wright S, Tevar S, Almeida RD, et al. ProBDNF induces neuronal apoptosis via activation of a receptor complex of p75 NTR and sortilin. J Neurosci. 2005;25(22):5455–63.
Koshimizu H, Kiyosue K, Hara T, Hazama S, Suzuki S, Uegaki K, et al. Multiple functions of precursor BDNF to CNS neurons: negative regulation of neurite growth, spine formation and cell survival. Mol Brain. 2009;2:27.
Fahnestock M, Michalski B, Xu B, Coughlin MD. The precursor pro-nerve growth factor is the predominant form of nerve growth factor in brain and is increased in Alzheimer’s disease. Mol Cell Neurosci. 2001;18(2):210–20.
Masoudi R, Ioannou MS, Coughlin MD, Pagadala P, Neet KE, Clewes O, et al. Biological activity of nerve growth factor precursor is dependent upon relative levels of its receptors. J Biol Chem. 2009;284(27):18424–33.
Bothwell M. NGF, BDNF, NT3, and NT4. Handb Exp Pharmacol. 2014;220:3–15.
Howe CL, Mobley WC. Long-distance retrograde neurotrophic signaling. Curr Opin Neurobiol. 2005;15(1):40–8.
De Nadai T, Marchetti L, Di Rienzo C, Calvello M, Signore G, Di Matteo P, et al. Precursor and mature NGF live tracking: one versus many at a time in the axons. Sci Rep. 2016;6:20272.
Shekari A, Fahnestock M. Retrograde axonal transport of BDNF and proNGF diminishes with age in basal forebrain cholinergic neurons. Neurobiol Aging. 2019;84:131–40.
Ioannou MS, Fahnestock M. ProNGF, but not NGF, switches from neurotrophic to apoptotic activity in response to reductions in TrKA receptor levels. Int J Mol Sci. 2017;18(3):599.
Holtzman DM, Kilbridge J, Li Y, Cunningham ET, Lenn NJ, Clary DO, et al. TrkA expression in the CNS: evidence for the existence of several novel NGF-responsive CNS neurons. J Neurosci. 1995;15(2):1567–76.
Hartikka J, Hefti F. Development of septal cholinergic neurons in culture: plating density and glial cells modulate effects of NGF on survival, fiber growth, and expression of transmitter-specific enzymes. J Neurosci. 1988;8(8):2967–85.
Bierl MA, Jones EE, Crutcher KA, Isaacson LG. “Mature” nerve growth factor is a minor species in most peripheral tissues. Neurosci Lett. 2005;380(1–2):133–7.
Maisonpierre PC, Belluscio L, Friedman B, Alderson RF, Wiegand SJ, Furth ME, et al. NT-3, BDNF, and NGF in the developing rat nervous system: parallel as well as reciprocal patterns of expression. Neuron. 1990;5(4):501–9.
Thoenen H, Barde YA. Physiology of nerve growth factor. Physiol Rev. 1980;60(4):1284–335.
Aloe L, Rocco M, Balzamino B, Micera A. Nerve growth factor: a focus on neuroscience and therapy. Curr Neuropharmacol. 2015;13(3):294–303.
Grimes ML, Zhou J, Beattie EC, Yuen EC, Hall DE, Valletta JS, et al. Endocytosis of activated TrkA: evidence that nerve growth factor induces formation of signaling endosomes. J Neurosci. 1996;16(24):7950–64.
Sieber-Blum M. Role of the neurotrophic factors BDNF and NGF in the commitment of pluripotent neural crest cells. Neuron. 1991;6(6):949–55.
Jones KR, Fariñas I, Backus C, Reichardt LF. Targeted disruption of the BDNF gene perturbs brain and sensory neuron development but not motor neuron development. Cell. 1994;76(6):989–99.
Ernfors P, Lee K, Jaenisch R. Mice lacking brain-derived neurotrophic factor develop with sensory deficits. Nature. 1994;368(March):147–50.
Ernfors P, Van De Water T, Loring J, Jaenisch R. Complementary roles of BDNF and NT-3 in vestibular and auditory development. Neuron. 1995;14(6):1153–64.
Conover JC, Erickson JT, Katz DM, Bianchi LM, Poueymirou WT, McClain J, et al. Neuronal deficits, not involving motor neurons, in mice lacking BDNF and/or NT4. Nature. 1995;375(6528):235–8.
Acheson A, Conover JC, Fandl JP, DeChiara TM, Russell M, Thadani A, et al. A BDNF autocrine loop in adult sensory neurons prevents cell death. Nature. 1995;374(6521):450–3.
Liu X, Jaenisch R. Severe peripheral sensory neuron loss and modest motor neuron reduction in mice with combined deficiency of brain-derived neurotrophic factor, neurotrophin 3 and neurotrophin 4/5. Dev Dyn. 2000;218(1):94–101.
Cohen-Cory S, Kidane AH, Shirkey NJ, Marshak S. Brain-derived neurotrophic factor and the development of structural neuronal connectivity. Dev Neurobiol. 2010 Apr;70(5):271–88.
Borghesani PR, Peyrin JM, Klein R, Rubin J, Carter AR, Schwartz PM, et al. BDNF stimulates migration of cerebellar granule cells. Development. 2002;129:1435–42.
Liu X, Somel M, Tang L, Yan Z, Jiang X, Guo S, et al. Extension of cortical synaptic development distinguishes humans from chimpanzees and macaques. Genome Res. 2012;22(4):611–22.
Webster MJ, Weickert CS, Herman MM, Kleinman JE. BDNF mRNA expression during postnatal development, maturation and aging of the human prefrontal cortex. Dev Brain Res. 2002;139(2):139–50.
Xu B, Zang K, Ruff NL, Zhang YA, McConnell SK, Stryker MP, et al. Cortical degeneration in the absence of neurotrophin signaling: dendritic retraction and neuronal loss after removal of the receptor TrkB. Neuron. 2000;26(1):233–45.
Cohen-Cory S, Fraser SE. BDNF in the development of the visual system of Xenopus. Neuron. 1994;12(4):747–61.
Shatz CJ, Stryker MP. Ocular dominance in layer IV of the cat’s visual cortex and the effects of monocular deprivation. J Physiol. 1978;281(1):267–83.
Hubel DH, Wiesel TN, LeVay S. Plasticity of ocular dominance columns in monkey striate cortex. Philos Trans R Soc B Biol Sci. 1977;278(961):377–409.
Domenici L, Berardi N, Carmignoto G, Vantini G, Maffei L. Nerve growth factor prevents the amblyopic effects of monocular deprivation. Proc Natl Acad Sci U S A. 1991;88(19):8811–5.
McAllister AK, Katz LC, Lo DC. Opposing roles for endogenous BDNF and NT-3 in regulating cortical dendritic growth. Neuron. 1997;18(5):767–78.
Cabelli RJ, Shelton DL, Segal RA, Shatz CJ. Blockade of endogenous ligands of TrkB inhibits formation of ocular dominance columns. Neuron. 1997;19(1):63–76.
Cellerino A, Maffei L, Domenici L. The distribution of brain-derived neurotrophic factor and its receptor trkB in parvlbumin-containing neurons of the rat visual cortex. Eur J Neurosci. 1996;8(6):1190–7.
Porcher C, Medina I, Gaiarsa JL. Mechanism of BDNF modulation in GABAergic synaptic transmission in healthy and disease brains. Front Cell Neurosci. 2018;12(August):1–9.
Fiorentino H, Kuczewski N, Diabira D, Ferrand N, Pangalos MN, Porcher C, et al. GABAB receptor activation triggers BDNF release and promotes the maturation of GABAergic synapses. J Neurosci. 2009;29(37):11650–61.
Ben-Ari Y, Gaiarsa J, Tyzio R, Khazipov R. GABA : a pioneer transmitter that excites immature neurons and generates primitive oscillations. Physiol Rev. 2007;87:1215–84.
Lu B, Nagappan G, Lu Y. BDNF and synaptic plasticity, cognitive function, and dysfunction. Handb Exp Pharmacol. 2014;220:223–50.
Kandel ER. The molecular biology of memory storage: a dialogue between genes and synapses. Science. 2001;294(5544):1030–8.
Korte M, Carroll P, Wolf E, Brem G, Thoenen H, Bonhoeffer T. Hippocampal long-term potentiation is impaired in mice lacking brain-derived neurotrophic factor. Proc Natl Acad Sci U S A. 1995;92(19):8856–60.
Minichiello L, Korte M, Wolfer D, Kühn R, Unsicker K, Cestari V, et al. Essential role for TrkB receptors in hippocampus-mediated learning. Neuron. 1999;24(2):401–14.
Yang J, Harte-Hargrove LC, Siao C, Marinic T, Clarke R, Ma Q, et al. proBDNF negatively regulates neuronal remodeling, synaptic transmission, and synaptic plasticity in hippocampus. Cell Rep. 2014;7(3):796–806.
Proenca CC, Song M, Lee FS. Differential effects of BDNF and neurotrophin 4 (NT4) on endocytic sorting of TrkB receptors. J Neurochem. 2017;138(3):397–406.
Lodovichi C, Berardi N, Pizzorusso T, Maffei L. Effects of neurotrophins on cortical plasticity: same or different? J Neurosci. 2000;20(6):2155–65.
Minichiello L, Casagranda F, Tatche RS, Stucky CL, Postigo A, Lewin GR, et al. Point mutation in trkB causes loss of NT4-dependent neurons without major effects on diverse BDNF responses. Neuron. 1998;21(2):335–45.
Chalazonitis A, Pham TD, Rothman TP, DiStefano PS, Bothwell M, Blair-Flynn J, et al. Neurotrophin-3 is required for the survival–differentiation of subsets of developing enteric neurons. J Neurosci. 2001;21(15):5620–36.
Chalazonitis A. Neurotrophin-3 in the development of the enteric nervous system. Prog Brain Res. 2004;146:243–63.
Stewart AL, Anderson RB, Kobayashi K, Young HM. Effects of NGF, NT-3 and GDNF family members on neurite outgrowth and migration from pelvic ganglia from embryonic and newborn mice. BMC Dev Biol. 2008;8(1):1–15.
Nagy N, Goldstein AM. Enteric nervous system development: a crest cell’s journey from neural tube to colon. Semin Cell Dev Biol. 2017;66:94–106.
Kuruvilla R, Zweifel LS, Glebova NO, Lonze BE, Valdez G, Ye H, et al. A neurotrophin signaling cascade coordinates sympathetic neuron development through differential control of TrkA trafficking and retrograde signaling. Cell. 2004;118(2):243–55.
Coelho RP, Yuelling LM, Fuss B, Sato-Bigbee C. Neurotrophin-3 targets the translational initiation machinery in oligodendrocytes. Glia. 2009;57(16):1754–64.
Glebova NO, Ginty DD. Growth and survival signals controlling sympathetic nervous system development. Annu Rev Neurosci. 2005;28(1):191–222.
Francis N, Farinas I, Brennan C, Rivas-Plata K, Backus C, Reichardt L, et al. NT-3, like NGF, is required for survival of sympathetic neurons, but not their precursors. Dev Biol. 1999;210(2):411–27.
Krimm RF, Davis BM, Albers KM. Cutaneous overexpression of neurotrophin-3 (NT3) selectively restores sensory innervation in NT3 gene knockout mice. J Neurobiol. 2000;43(1):40–9.
Kumar A, Pareek V, Faiq MA, Ghosh SK, Kumari C. Adult neurogenesis in humans: a review of basic concepts, history, current research, and clinical implications. Innov Clin Neurosci. 2019;16(5–6):30–7.
Yau S, Li A, So K-F. Involvement of adult hippocampal neurogenesis in learning and forgetting. Neural Plast. 2015;2015:1–13.
Numakawa T, Odaka H, Adachi N. Actions of brain-derived neurotrophic factor and glucocorticoid stress in neurogenesis. Int J Mol Sci. 2017;18(11):2312.
Troca-Marín JA, Alves-Sampaio A, Montesinos ML. Deregulated mTOR-mediated translation in intellectual disability. Prog Neurobiol. 2012;96(2):268–82.
Nicolini C, Ahn Y, Michalski B, Rho JM, Fahnestock M. Decreased mTOR signaling pathway in human idiopathic autism and in rats exposed to valproic acid. Acta Neuropathol Commun. 2015;3(3):1–13.
Nicolini C, Fahnestock M. The valproic acid-induced rodent model of autism. Exp Neurol. 2018;299:217–27.
Sandin S, Lichtenstein P, Kuja-Halkola R, Larsson H, Hultman CM, Reichenberg A. The familial risk of autism. JAMA. 2014;311(17):1770–7.
Kelleher RJ, Bear MF. The autistic neuron: troubled translation? Cell. 2008;135(3):401–6.
Morimoto K, Fahnestock M, Racine RJ. Kindling and status epilepticus models of epilepsy: rewiring the brain. Prog Neurobiol. 2004;73(1):1–60.
Adams B, Sazgar M, Osehobo P, Van der Zee CEEM, Diamond J, Fahnestock M, et al. Nerve growth factor accelerates seizure development, enhances mossy fiber sprouting, and attenuates seizure-induced decreases in neuronal density in the kindling model of epilepsy. J Neurosci. 1997;17(14):5288–96.
Ben-Ari Y, Holmes GL. The multiple facets of γ-aminobutyric acid dysfunction in epilepsy. Curr Opin Neurol. 2005;18(2):141–5.
Boschen KE, Klintsova AY. Neurotrophins in the brain: interaction with alcohol exposure during development. Vitam Horm. 2017;4(104):197–242.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2023 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Shekari, A., Mahadeo, C., Sanwalka, N., Fahnestock, M. (2023). Neurotrophins and Cell Death. In: Eisenstat, D.D., Goldowitz, D., Oberlander, T.F., Yager, J.Y. (eds) Neurodevelopmental Pediatrics. Springer, Cham. https://doi.org/10.1007/978-3-031-20792-1_4
Download citation
DOI: https://doi.org/10.1007/978-3-031-20792-1_4
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-031-20791-4
Online ISBN: 978-3-031-20792-1
eBook Packages: MedicineMedicine (R0)